BCAL Diagnostics Limited

ASX (AUD): BCAL Diagnostics Limited (BDX)

Last Price

0.077

Today's Change

-0.009 (10.46%)

Day's Change

0.077 - 0.085

Trading Volume

156,026

Overview

Market Cap

28 Million

Shares Outstanding

365 Million

Avg Volume

293,399

Avg Price (50 Days)

0.10

Avg Price (200 Days)

0.11

PE Ratio

-2.57

EPS

-0.03

Earnings Announcement

02-Sep-2025

Previous Close

0.09

Open

0.09

Day's Range

0.077 - 0.085

Year Range

0.077 - 0.185

Trading Volume

156,026

Price Change Highlight

1 Day Change

-10.47%

5 Day Change

-10.47%

1 Month Change

-26.67%

3 Month Change

-17.20%

6 Month Change

-35.83%

Ytd Change

-20.62%

1 Year Change

-16.30%

3 Year Change

-26.67%

5 Year Change

-69.20%

10 Year Change

-69.20%

Max Change

-69.20%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment